A significant reduction of the primary end point, mortality and hospitalization, from 36% (CRT-P) were shown. The authors found that in patients with heart failure and cardiac dyssynchrony ...

After CRT, older and younger patients had similar improvements in NHYA class (P = 0.41), ejection fraction (P = 0.48), and mitral valve regurgitation (MR) severity (P = 0.42). In the older ...

The outcomes of this trial help confirm that cisplatin chemotherapy given adjuvantly with radiotherapy is not a superior alternative ,” said Sang Young Ryu, MD.